Joseph C. Oguegbulu received his Masters in Medicinal Chemistry from the University of Strathclyde, Glasgow, UK in 2015, and is now pursuing a PhD in Pharmaceutical and Medicinal Chemistry. He works as a Lecturer at Bingham University, Karu, Nigeria (2016-present). In 2022/23, he worked in the Drug Discovery Laboratory of the Medical University of South Carolina, Charleston, SC, USA as a Fulbright Visiting Student Researcher as part of his PhD. His research works mainly include anti-infective drug hybridisation, malaria drug discovery, and drug design and organic synthesis.
Joseph C. Oguegbulu received his Masters in Medicinal Chemistry from the University of Strathclyde, Glasgow, UK in 2015, and is now pursuing a PhD in Pharmaceutical and Medicinal Chemistry. He works as a Lecturer at Bingham University, Karu, Nigeria (2016-present). In 2022/23, he worked in the Drug Discovery Laboratory of the Medical University of South Carolina, Charleston, SC, USA as a Fulbright Visiting Student Researcher as part of his PhD. His research works mainly include anti-infective drug hybridisation, malaria drug discovery, and drug design and organic synthesis.